Categories
Archives
Receive Email Updates

-


-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me

Warren D. Woessner
Pages
Archives
Author Archives: Warren Woessner
SECOND PAIR OF EYES REVIEW – IS THE WICKED WITCH REALLY DEAD?
I have heard rumors for some months that the dreaded “Second Pair of Eyes” review of Examiners’ intent-to-allow patent applications had been eliminated. For those of you who are not on the front lines of patent prosecution, the “SPOE” review … Continue reading
Posted in USPTO Practice and Policy
Tagged AIPLA, David Kappos, Patent Law, QPQA, SPOE, Warren Woessner
Leave a comment
JUDGE RADER DEFENDS THE FUTURE OF IP
Judge Randall Rader of the Federal Circuit was the luncheon speaker at the AIPLA Annual Meeting Friday in DC and, as usual, he spoke well. So many of his fellow- (and one female) judges where there that he quipped: “Now … Continue reading
TALKING WRITTEN DESCRIPTION REQUIREMENT BLUES – ARIAD WOBBLES
On October 5, 2009, Ariad filed a 60 page brief (not counting attached appendices) with the Federal Circuit in support of its appeal in Ariad v. Lilly. (Attached below.) As you will recall from my post of August 24th, the … Continue reading
Director Kappos Kills Prosecution Regulations Package
Two years of fear and loathing have ended, as the USPTO has announced that it is rescinding the “Continuations” and “Claims” rules that have been hanging over the heads of practitioners, and will move to dismiss/vacate the pending lawsuit over … Continue reading
Posted in USPTO Practice and Policy
Tagged David Kappos, Dr. Tafas, Federal Circuit, Glaxo, USPTO, USPTO examiner, USPTO rules, Warren Woessner
1 Comment
